Covestor’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
Covestor's ORGO Position: Q3 2026 in Review
Covestor reduced its Organogenesis Holdings (ORGO) stake by 40% in Q3 2026, selling an estimated $122 and leaving 94 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2705.
Covestor first reported a position in ORGO in Q4 2021 and has held it in 20 quarters since. The position peaked at $1K in Q2 2022. 54 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.
- Covestor held 94 shares of Organogenesis Holdings worth $0 as of Q3 2026.
- Covestor sold 62 Organogenesis Holdings shares in Q3 2026, an estimated $122.
- Organogenesis Holdings made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2705 holding.
- Covestor first reported a position in Organogenesis Holdings in Q4 2021 and has held it in 20 quarters since.
- Covestor's Organogenesis Holdings position peaked at $1K in Q2 2022.
- 54 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.